| Value | ₹336.1 Cr |
|---|
NSE filing, NSE: 360ONE. Summary written from the filing by ALFA Finder's alert engine.
360 One Wam Ltd: key numbers
- Share price
- ₹1,011.00
- Market cap
- ₹43,360 Cr
- Revenue (annual)
- ₹4,362 Cr
- Net profit (annual)
- ₹1,216 Cr
- P/E (TTM)
- 34.8×Sector 19.1×
- Promoter holding
- 5.88%-0.32% QoQ
- FII holding
- 56.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 360 One Wam Ltd
All →360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
360 One Wam Other Announcement
360 ONE WAM sold 1,200 equity shares worth Rs.12,26,292 on NSE on 23 October 2026 under a PIT disclosure. The seller is a Designated Person, and the holding fell to zero.
- Value
- ₹0.12 Cr
360 One Wam Employee Stock Options
360 ONE WAM LIMITED allotted 4,61,384 equity shares to employees following the exercise of stock options under its ESOP scheme.
360 One Wam Debt & Borrowing: ₹200 Cr
360 ONE WAM redeemed its ₹200 Crore Commercial Paper in full at maturity on 22 October 2026. The entire principal was repaid to investors.
- Value
- ₹200.0 Cr
360 One Wam Convertible Warrants
UBS AG warrants converted into 2.05 crore equity shares at Rs.1,030 each. Balance 75% exercise price of Rs.1,583.85 Crore received by 360 ONE WAM.
- Value
- ₹1,584 Cr
360 One Wam Convertible Warrants
360 ONE WAM allotted 2,05,02,939 shares to UBS AG on warrant conversion at Rs.1,030 each. Consideration: Rs.2,111.80 Crore, giving UBS ~4.8%.
- Value
- ₹2,112 Cr
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.